Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 06 Feb 2023

A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses

in Vaccines and Molecular Therapeutics

Véronique Corbière
Eleonora E. Lambert
Marine Rodesch
Jacqueline A. M. van Gaans-van den Brink
Alicja Misiak
Elles Simonetti
Anne Van Praet
Audrey Godefroid
Dimitri A. Diavatopoulos
Cécile A. C. M. van Els

Frontiers in Immunology

doi 10.3389/fimmu.2023.1101366

4,226 views
6 citations

Mini Review

Published on 03 Feb 2023

Precision-engineering of subunit vaccine particles for prevention of infectious diseases

in Vaccines and Molecular Therapeutics

Shuxiong Chen
Saranya Pounraj
Nivethika Sivakumaran
Anjali Kakkanat
Gayathri Sam
Md. Tanvir Kabir
Bernd H. A. Rehm

Frontiers in Immunology

doi 10.3389/fimmu.2023.1131057

8,987 views
24 citations

Original Research

Published on 03 Feb 2023

Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting

in Vaccines and Molecular Therapeutics

James H. A. Clubb
Tatiana V. Kudling
Mykhailo Girych
Lyna Haybout
Santeri Pakola
Firas Hamdan
Víctor Cervera-Carrascon
Annabrita Hemmes
Susanna Grönberg-Vähä-Koskela
João Manuel Santos

Frontiers in Immunology

doi 10.3389/fimmu.2023.1060540

20,018 views
8 citations

Original Research

Published on 02 Feb 2023

Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study

in Vaccines and Molecular Therapeutics

Sarra Mestiri
Maysaloun Merhi
Varghese P. Inchakalody
Nassiba Taib
Maria K. Smatti
Fareed Ahmad
Afsheen Raza
Fatma H. Ali
Shereena Hydrose
Queenie Fernandes

Frontiers in Immunology

doi 10.3389/fimmu.2023.1061255

4,520 views
3 citations

Original Research

Published on 02 Feb 2023

Global trends of Vaccinia oncolytic virus therapy over the past two decades: Bibliometric and visual analysis

in Vaccines and Molecular Therapeutics

Liu Bo
Liu Tianming
Fan Fengliang
Liang Wenping
Han Jinzuo
Xue Dongbo
Ma Biao
Sun Haijun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1063548

3,564 views
1 citation

Original Research

Published on 02 Feb 2023

Design of a multi-epitope vaccine against six Nocardia species based on reverse vaccinology combined with immunoinformatics

in Vaccines and Molecular Therapeutics

Fei Zhu
Caixia Tan
Chunhui Li
Shiyang Ma
Haicheng Wen
Hang Yang
Mingjun Rao
Peipei Zhang
Wenzhong Peng
Yanhui Cui

Frontiers in Immunology

doi 10.3389/fimmu.2023.1100188

11,802 views
25 citations

Original Research

Published on 02 Feb 2023

Role of mTOR inhibitor in the cellular and humoral immune response to a booster dose of SARS-CoV-2 mRNA-1273 vaccine in kidney transplant recipients

in Vaccines and Molecular Therapeutics

Isabel Pérez-Flores
Ignacio Juarez
Arianne S. Aiffil Meneses
Ana Lopez-Gomez
Natividad Calvo Romero
Beatriz Rodriguez-Cubillo
María Angeles Moreno de la Higuera
Belen Peix-Jiménez
Raquel Gonzalez-Garcia
Elvira Baos-Muñoz

Frontiers in Immunology

doi 10.3389/fimmu.2023.1111569

4,031 views
7 citations

Brief Research Report

Published on 31 Jan 2023

SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus

in Vaccines and Molecular Therapeutics

Almohanad A. Alkayyal
Reham Ajina
Marco Cacciabue
Aaesha A. Alkayyal
Nizar H. Saeedi
Taofik Hussain Alshehry
Feras Kaboha
Mohammed A. Alotaibi
Nada Zaidan
Khalid Shah

Frontiers in Immunology

doi 10.3389/fimmu.2023.1082191

5,252 views
2 citations

Original Research

Published on 31 Jan 2023

A novel, non-neuronal acetylcholinesterase of schistosome parasites is essential for definitive host infection

in Vaccines and Molecular Therapeutics

Patrick J. Skelly
Akram A. Da’dara

Frontiers in Immunology

doi 10.3389/fimmu.2023.1056469

3,207 views
10 citations

Review

Published on 31 Jan 2023

Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19

in Vaccines and Molecular Therapeutics

Jingli Du
Yue Su
Ruilan Wang
Enjun Dong
Yan Cao
Wenjuan Zhao
Wenping Gong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1118378

9,519 views
7 citations

Original Research

Published on 30 Jan 2023

Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines

in Vaccines and Molecular Therapeutics

Shaojun Liu
Joseph G. S. Tsun
Genevieve P. G. Fung
Grace C. Y. Lui
Kathy Y. Y. Chan
Paul K. S. Chan
Renee W. Y. Chan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1127401

3,849 views
8 citations

Original Research

Published on 30 Jan 2023

Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature

in Vaccines and Molecular Therapeutics

Janneke W. Duijster
Thomas Lieber
Silvia Pacelli
Leontine Van Balveren
Loes S. Ruijs
Monika Raethke
Agnes Kant
Florence Van Hunsel

Frontiers in Immunology

doi 10.3389/fimmu.2023.1078736

9,074 views
35 citations

Original Research

Published on 27 Jan 2023

Bioinformatics analysis and consistency verification of a novel tuberculosis vaccine candidate HP13138PB

in Vaccines and Molecular Therapeutics

Peng Cheng
Fan Jiang
Guiyuan Wang
Jie Wang
Yong Xue
Liang Wang
Wenping Gong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1102578

7,500 views
26 citations

Original Research

Published on 27 Jan 2023

Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern

in Vaccines and Molecular Therapeutics

Steven Y. Gao
Nancy B. Amaro-Mugridge
Jocelyn Madrid-Weiss
Nikolina Petkovic
Natasha Vanegas
Kumar Visvanathan
Bryan R. G. Williams
Jennifer A. MacDiarmid
Himanshu Brahmbhatt

Frontiers in Immunology

doi 10.3389/fimmu.2022.1038562

6,407 views
2 citations

Original Research

Published on 27 Jan 2023

Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters

in Vaccines and Molecular Therapeutics

Maria Rescigno
Chiara Agrati
Carlo Salvarani
Diana Giannarelli
Massimo Costantini
Alberto Mantovani
Raffaella Massafra
Pier Luigi Zinzani
Aldo Morrone
Stefania Notari

Frontiers in Immunology

doi 10.3389/fimmu.2023.1104124

5,337 views
18 citations

Original Research

Published on 26 Jan 2023

Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets

in Vaccines and Molecular Therapeutics

Muhammad Waqas
Shahkaar Aziz
Pietro Liò
Yumna Khan
Amjad Ali
Aqib Iqbal
Faizullah Khan
Fahad Nasser Almajhdi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1091941

12,518 views
33 citations